Patient barriers to and enablers of deprescribing: A systematic review

Drugs and Aging

Volumn 30, Issue 10, 2013, Pages 793-807

  Reeve, Emily ^a,b   To, Josephine ^a   Hendrix, Ivanka ^c   Shakib, Sepehr ^b   Roberts, Michael S ^a,d   Wiese, Michael D ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BETA1A INTERFERON; DONEPEZIL; METHADONE; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

CINAHL; CONSUMER; CONTENT ANALYSIS; DATA EXTRACTION; DRUG WITHDRAWAL; EMBASE; HEALTH CARE; HORMONE SUBSTITUTION; HUMAN; MEDLINE; PATIENT CARE; PATIENT DECISION MAKING; PRIORITY JOURNAL; REVIEW; SYNTHESIS; SYSTEMATIC REVIEW;

DECISION MAKING; HUMANS; INAPPROPRIATE PRESCRIBING; PATIENT SAFETY; WITHHOLDING TREATMENT;

EID: 84890247826     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0106-8     Document Type: Review

References (72)

1. Guaraldo L, Cano FG, Damasceno GS, Rozenfeld S. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatrics. 2011;11:79.
2. Elliott R. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36:58-66.
3. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516-23. (Pubitemid 44564145)
4. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348-58. (Pubitemid 40381487)
5. Dedhiya SD, Hancock E, Craig BA, Doebbeling CC, Thomas J. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2010;8:562-70.
6. Chrischilles EA, VanGilder R, Wright K, Kelly M, Wallace RB. Inappropriate medication use as a risk factor for self reported adverse drug effects in older adults. J Am Geriatr Soc. 2009;57:1000-6.
7. Holmes H. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther. 2008;85:103-7.
8. Dimitrow MS, Airaksinen MSA, Kivelä SL, Lyles A, Leikola SNS. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc. 2011;59:1521-30.
9. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28:237-53.
10. Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26:1013-28.
11. Woodward M. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323-8. (Pubitemid 38035980)
12. Le Couteur DG, Banks E, Gnjidic D, McLachlan A. Deprescribing. Aust Prescr. 2011;34:182-5.
13. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25:1021-31.
14. Hering-Hanit R, Yavetz A, Dagan Y. Effect of withdrawal of misused medication on sleep disturbances in migraine sufferers with chronic daily headache. Headache. 2000;40:809-12. (Pubitemid 32053241)
15. Alexander GC, Sayla MA, Holmes HM, Sachs GA. Prioritizing and stopping prescription medicines. Can Med Assoc J. 2006;174:1083-4.
16. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56:1946-52.
17. Ostini R, Hegney D, Jackson C, Tett SE. Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manage Care Pharm. 2012;18:68.
18. Scott I, Gray L, Martin J, Mitchell C. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125:529-37.
19. Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K, et al. Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009;43:502-13.
20. Reeve E, Wiese MD, Hendrix I, Roberts M, Shakib S. Patient attitudes, beliefs and experiences of polypharmacy and willingness of deprescribing. J Am Geriatr Soc. 2013 (accepted).
21. Beer C, Loh Pk, Peng YG, Potter K, Millar A. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2:37-43.
22. Williams M, Pulliam C, Hunter R, Johnson T, Owens J, Kincaid J, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93-8. (Pubitemid 38090396)
23. van Duijn HJ, Belo JN, Blom JW, Velberg ID, Assendelft WJ. Revised guidelines for cardiovascular risk management time to stop medication? A practice-based intervention study. Br J Gen Pract. 2011;61:e347-52.
24. Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother. 2010;44:1725-32.
25. Fried TR, McGraw S, Agostini JV, Tinetti ME. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008;56:1839-44.
26. TRIP. Trip database. 2012. http://www.tripdatabase.com (Accessed 1 July 2013).
27. The Joanna Briggs Institute. Systematic review registered trials. University of Adelaide. 2013. http://www.joannabriggs.edu.au (Accessed 1 July 2013).
28. Dixon-Woods M, Bonas S, Booth A, Jones DR, Miller T, Sutton AJ, et al. How can systematic reviews incorporate qualitative research? A critical perspective. Qual Res. 2006;6:27-44. (Pubitemid 43650772)
29. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M et al. Guidance on the conduct of narrative synthesis in systematic reviews. Lancaster: Institute of Health Research, ESRC Methods Programme; 2006.
30. Dixon-Woods M, Fitzpatrick R, Roberts K. Including qualitative research in systematic reviews: opportunities and problems. J Eval Clin Pract. 2001;7:125-33. (Pubitemid 32489006)
31. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349-57. (Pubitemid 350186969)
32. Straand J, Sandvik H. Stopping long-term drug therapy in general practice. How well do physicians and patients agree? Fam Pract. 2001;18:597-601. (Pubitemid 34026583)
33. Barter G, Cormack M. The long-term use of benzodiazepines: patients' views, accounts and experiences. Fam Pract. 1996;13:491-7. (Pubitemid 27060084)
34. Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med. 2007;22:1094-100. (Pubitemid 47038041)
35. Iliffe S, Curran HV, Collins R, Kee SC, Fletcher S, Woods B. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health. 2004;8:242-8. (Pubitemid 38639439)
36. King MB, Gabe J, Williams P, Rodrigo EK. Long term use of benzodiazepines: the views of patients. Br J Gen Pract. 1990;40:194-6. (Pubitemid 20196066)
37. Parr JM, Kavanagh DJ, Young RM, McCafferty K. Views of general practitioners and benzodiazepine users on benzodiazepines: a qualitative analysis. Soc Sci Med. 2006;62:1237-49. (Pubitemid 43129587)
38. Roe D, Goldblatt H, Baloush-Klienman V, Swarbrick M, Davidson L. Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice. Psychiatr Rehabil J. 2009;33:38-46.
39. Moses T. Adolescents' commitment to continuing psychotropic medication: a preliminary investigation of considerations, contradictions, and correlates. Child Psychiatry Hum Dev. 2011;42:93-117.
40. Haslam C, Brown S, Atkinson S, Haslam R. Patients' experiences of medication for anxiety and depression: effects on working life. Fam Pract. 2004;21:204-12. (Pubitemid 38489406)
41. Leydon GM, Rodgers L, Kendrick T. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract. 2007;24:570-5.
42. Verbeek-Heida P, Mathot E. Better safe than sorry - why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. Chronic Illn. 2006;2:133-42. (Pubitemid 44014759)
43. Post SG, Stuckey JC, Whitehouse PJ, Ollerton S, Durkin C, Robbins D, et al. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers. Alzheimer Dis Assoc Disord. 2001;15:80-8. (Pubitemid 32525446)
44. Gold ML, Sorences JL, McCanlies N, Trier M, Dlugosch G. Tapering from methadone maintenance: Attitudes of clients and staff. J Subst Abuse Treat. 1988;5:37-44. (Pubitemid 18090170)
45. Kilinç S, Campbell C. The experience of discontinuing antiepileptic drug treatment: An exploratory investigation. Seizure. 2008;17:505-13.
46. Bertero C, Johansson G. Compliance with hormone replacement therapy among Swedish women. Int Nurs Rev. 2001;48:224-32. (Pubitemid 33632912)
47. Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas. 2007;56:420-8. (Pubitemid 46420499)
48. Horner E, Fleming J, Studd J. A study of women on long-term hormone replacement therapy and their attitude to suggested cessation. Climacteric. 2006;9:459-63. (Pubitemid 44691461)
49. Boath EH, Blenkinsopp A. The rise and rise of proton pump inhibitor drugs: patients' perspectives. Soc Sci Med. 1997;45:1571-9. (Pubitemid 27455285)
50. Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: perspectives of patients and their GPs. Br J Gen Pract. 2001;51:703.
51. Berger BA, Hudmon KS, Liang H. Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change. J Am Pharm Assoc. 2004;44:445-54.
52. Benson J, Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873.
53. O'Connor M, Gallagher P, O'Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29:437.
54. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. 2013;35:51-6.
55. Dolovich L, Nair K, Sellors C, Lohfeld L, Lee A, Levine M. Do patients' expectations influence their use of medications? Qualitative study. Can Fam Physician. 2008;54:384-93. (Pubitemid 351413663)
56. Morecroft C, Cantrill J, Tully MP. Patients' evaluation of the appropriateness of their hypertension management - a qualitative study. Res Social Adm Pharm. 2006;2:186-211. (Pubitemid 43903395)
57. Krol N, Wensing M, Haaijer-Ruskamp F, Muris JW, Numans ME, Schattenberg G, et al. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial. Aliment Pharmacol Ther. 2004;19:917-22. (Pubitemid 38534821)
58. Haddad P. Do antidepressants have any potential to cause addiction? J Psychopharmacol. 1999;13:300-7. (Pubitemid 29435798)
59. Charach A, Skyba A, Cook L, Antle BJ. Using stimulant medication for children with ADHD: What do parents say? A brief report. J Can Acad Child Adolesc Psychiatry. 2006;15:75-83. (Pubitemid 43810951)
60. Graves T, Hanlon JT, Schmader KE, Landsman PB, Samsa GP, Pieper CF, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med. 1997;157:2205-10. (Pubitemid 27451146)
61. Inadomi JM, Jamal R, Murata GH, Hoffman RM, Lavezo LA, Vigil JM, et al. Step-down management of gastroesophageal reflux disease. Gastroenterology. 2001;121:1095-100. (Pubitemid 33022089)
62. Raghunath A, Hungin A, Cornford C, Featherstone V. Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners. Digestion. 2005;72:212-8. (Pubitemid 41820803)
63. Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44:408-12. (Pubitemid 24292665)
64. Espeland MA, Whelton PK, Kostis JB, Bahnson JL, Ettinger WH, Cutler JA, et al. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. Arch Fam Med. 1999;8:228-36.
65. Hesse BW, Nelson DE, Kreps GL, Croyle RT, Arora NK, Rimer BK, et al. Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey. Arch Intern Med. 2005;165:2618. (Pubitemid 41785059)
66. Zermansky AG. Who controls repeats? Br J Gen Pract. 1996;46:643.
67. Schuling J, Gebben H, Veehof LJG, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56.
68. Mays N, Pope C. Assessing quality in qualitative research. BMJ. 2000;320:50-2.
69. Meeks TW, Culberson JW, Horton MS. Medications in long-term care: when less is more. Clin Geriatr Med. 2011;27:171-91.
70. Hardy JE, Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res. 2011.
71. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000;25:333-40. (Pubitemid 32002877)
72. Poses RM, Isen AM. Qualitative research in medicine and health care. J Gen Intern Med. 1998;13:32-8. (Pubitemid 28063534)